| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/MT.2009.153 |
| P8608 | Fatcat ID | release_sldfpdxyh5cf7iyi6rkrvm7ghi |
| P932 | PMC publication ID | 2835036 |
| P698 | PubMed publication ID | 19603006 |
| P5875 | ResearchGate publication ID | 26671592 |
| P50 | author | Sang Wan Kim | Q40350095 |
| Hyung Jin Choi | Q51350269 | ||
| P2093 | author name string | Jee Hyun An | |
| Seong Yeon Kim | |||
| Hyun Jin Sun | |||
| Dohee Kim | |||
| Chan Soo Shin | |||
| Ju Yeon Jung | |||
| Jae-Yeon Yang | |||
| Sun Wook Cho | |||
| Hwa Young Cho | |||
| P2860 | cites work | RANK is essential for osteoclast and lymph node development | Q24598872 |
| osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 | ||
| Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| RANKL-RANK signaling in osteoclastogenesis and bone disease | Q28287091 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Transplanted bone marrow cells localize to fracture callus in a mouse model | Q30310312 | ||
| Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression | Q33944735 | ||
| Severely suppressed bone turnover: a potential complication of alendronate therapy | Q33983792 | ||
| Osteoporosis prevention, diagnosis, and therapy | Q34140339 | ||
| Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis | Q34418159 | ||
| Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women | Q34803284 | ||
| Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis | Q34803295 | ||
| The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice | Q34926717 | ||
| Molecular cloning and structure of a pre-B-cell growth-stimulating factor | Q35106000 | ||
| The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. | Q36376700 | ||
| B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement | Q36400397 | ||
| Targeting the RANK/RANKL/OPG signaling pathway: a novel approach in the management of osteoporosis | Q36801298 | ||
| Adult mesenchymal stem cells: a pluripotent population with multiple applications | Q37066506 | ||
| RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 | ||
| Anti-resorptives in the management of osteoporosis | Q37333079 | ||
| Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system | Q39025149 | ||
| Retroviruses and the study of cell lineage. | Q39702779 | ||
| HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver | Q39785808 | ||
| Enhanced functional response to CXCL12/SDF-1 through retroviral overexpression of CXCR4 on M07e cells: implications for hematopoietic stem cell transplantation | Q40306487 | ||
| Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes | Q40581164 | ||
| Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function | Q40736018 | ||
| Selective transendothelial migration of hematopoietic progenitor cells: a role in homing of progenitor cells. | Q40986211 | ||
| The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. | Q41649459 | ||
| Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells | Q42437094 | ||
| Presentation of chemokine SDF-1 alpha by fibronectin mediates directed migration of T cells. | Q42494257 | ||
| Calcineurin mediates the calcium-dependent inhibition of adipocyte differentiation in 3T3-L1 cells | Q42809969 | ||
| Retrovirus-mediated gene transfer of receptor activator of nuclear factor-kappaB-Fc prevents bone loss in ovariectomized mice | Q45856973 | ||
| Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats | Q45858232 | ||
| Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells | Q45858451 | ||
| Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation | Q45874391 | ||
| Bone development and age-related bone loss in male C57BL/6J mice | Q46286440 | ||
| Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction. | Q50672733 | ||
| Efficacy of bone marrow-derived stem cells in strengthening osteoporotic bone in a rabbit model. | Q50720359 | ||
| The role of bone marrow-derived cells in bone fracture repair in a green fluorescent protein chimeric mouse model. | Q50770703 | ||
| Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. | Q50963245 | ||
| Genetic variability in adult bone density among inbred strains of mice. | Q52201749 | ||
| Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. | Q53547964 | ||
| Patients' voices: the powerful sound in the stem cell debate | Q73479404 | ||
| Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4 | Q77952550 | ||
| Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone | Q79317200 | ||
| Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium | Q79842788 | ||
| Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion | Q79862803 | ||
| Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance | Q80641442 | ||
| Nonprimate animal models of menopause: workshop report | Q93929231 | ||
| P433 | issue | 11 | |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| overexpression | Q61643320 | ||
| P304 | page(s) | 1979-1987 | |
| P577 | publication date | 2009-07-14 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice | |
| P478 | volume | 17 |
| Q34346254 | Adipose lineage specification of bone marrow-derived myeloid cells |
| Q41261677 | Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis. |
| Q26744340 | Bone repair with skeletal stem cells: rationale, progress to date and clinical application |
| Q40962002 | CXCR4 expression is associated with time-course permanent and temporary myocardial infarction in rats |
| Q64253973 | CXCR4-Overexpressing Umbilical Cord Mesenchymal Stem Cells Enhance Protection against Radiation-Induced Lung Injury |
| Q42281679 | CXCR4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injury |
| Q47762656 | Concise Review: Musculoskeletal Stem Cells to Treat Age-Related Osteoporosis. |
| Q36570943 | De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissue |
| Q37128607 | Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass |
| Q35925142 | Effect of Stem Cell Therapy on Bone Mineral Density: A Meta-Analysis of Preclinical Studies in Animal Models of Osteoporosis |
| Q38207147 | Emerging therapeutic targets for osteoporosis treatment |
| Q27026414 | Engineering mesenchymal stem cells for regenerative medicine and drug delivery |
| Q60301629 | Gender-independent efficacy of mesenchymal stem cell therapy in sex hormone-deficient bone loss via immunosuppression and resident stem cell recovery |
| Q33908836 | Interleukin-3 enhances the migration of human mesenchymal stem cells by regulating expression of CXCR4. |
| Q97425610 | Local SDF-1α application enhances the therapeutic efficacy of BMSCs transplantation in osteoporotic bone healing |
| Q39356606 | MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation |
| Q58720492 | Mesenchymal Stem Cell Therapy for Bone Regeneration |
| Q89777604 | Mesenchymal stem cells expressing osteoprotegerin variants inhibit osteolysis in a murine model of multiple myeloma |
| Q47269873 | Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts |
| Q36757035 | MiR-26a Rescues Bone Regeneration Deficiency of Mesenchymal Stem Cells Derived From Osteoporotic Mice |
| Q36003387 | Molecular genetic studies of gene identification for osteoporosis: the 2009 update |
| Q33856984 | Osteoporosis and ageing affects the migration of stem cells and this is ameliorated by transfection with CXCR4. |
| Q44128685 | Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells |
| Q35766784 | RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease |
| Q33588206 | Recipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on Osteopenia |
| Q37227409 | Reversing bone loss by directing mesenchymal stem cells to bone. |
| Q35226489 | SDF-1/CXCR4 axis in Tie2-lineage cells including endothelial progenitor cells contributes to bone fracture healing |
| Q37075242 | Screening of osteoprotegerin-related feature genes in osteoporosis and functional analysis with DNA microarray |
| Q38177180 | Stem cell therapy for osteoporosis. |
| Q92682410 | Stem cell-based bone and dental regeneration: a view of microenvironmental modulation |
| Q91688583 | Stem cells in Osteoporosis: From Biology to New Therapeutic Approaches |
| Q36808571 | Systemic Mesenchymal Stromal Cell Transplantation Prevents Functional Bone Loss in a Mouse Model of Age-Related Osteoporosis |
| Q34716765 | Targeted delivery of mesenchymal stem cells to the bone |
| Q49987830 | Targeting Murine Mesenchymal Stem Cells to Kidney Injury Molecule-1 Improves Their Therapeutic Efficacy in Chronic Ischemic Kidney Injury |
| Q27008643 | The applications of buckminsterfullerene C60 and derivatives in orthopaedic research |
| Q38057676 | Therapeutic application of mesenchymal stem cells in bone and joint diseases |
| Q36600189 | Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice |
| Q37110197 | Ubiquitin E3 ligase Wwp1 negatively regulates osteoblast function by inhibiting osteoblast differentiation and migration |
| Q48215647 | Umbilical cord extracts improve osteoporotic abnormalities of bone marrow-derived mesenchymal stem cells and promote their therapeutic effects on ovariectomised rats |
Search more.